---
title: "SpringWorks Therapeutics jumps on report of Merck KGaA takeover talks"
date: "2025-02-10 18:00:15"
summary: "SpringWorks Therapeutics (NASDAQ:SWTX) soared 12% after a report that Merck KGaA (OTCPK:MKGAF) is in advanced discussions to acquire the cancer and rare disease drugmaker. If an agreement is reached, it could be signed in the coming weeks, according to a Reuters report on Monday, which cited people familiar with the..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1214042271/image_1214042271.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

SpringWorks Therapeutics (NASDAQ:[SWTX](https://seekingalpha.com/symbol/SWTX "SpringWorks Therapeutics, Inc.")) soared 12% after a report that Merck KGaA ([OTCPK:MKGAF](https://seekingalpha.com/symbol/MKGAF "Merck KGaA")) is in advanced discussions to acquire the cancer and rare disease drugmaker.

If an agreement is reached, it could be signed in the coming weeks, according to a Reuters report on Monday, which cited people familiar with the matter. The exact terms of a potential deal weren't known.

SpringWorks declined to comment to Reuters.

SpringWorks has a market cap of $3 billion.

[seekalpha](https://seekingalpha.com/news/4405616-springworks-therapeutics-jumps-on-report-of-merck-kgaa-takeover-talks)
